Dr Lisa Kalisch Ellett
NHMRC
Australia
Medicine-associated dementia and cognitive impairment: identifying the problem, reducing the harm
NHMRC
339,880
01/01/16
5.0
Alzheimer's disease & other dementias
health promotion | adverse effects | quality use | pharmacoepidemiology | dementia
Several studies have shown an association between use of anticholinergic or sedative medicines and increased risk of dementia. Questions remain about whether these medicines cause dementia (or are just used by people already at risk), whether or not cognitive function improves if the medicines are stopped or if the dose is reduced, and the characteristics of patients most likely to use these medicines. This program of research aims to answer these questions.